Cost-effectiveness of pneumococcal vaccination policies and uptake programs in US older populations

BACKGROUND/OBJECTIVES: Recently revised vaccination recommendations for US adults ≥65 years old include both pneumococcal polysaccharide vaccine (PPSV23) and pneumococcal conjugate vaccine (PCV13), with PCV13 now recommended for immunocompetent seniors based on shared decision making. The public hea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Geriatr Soc
Egile Nagusiak: Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299822/
https://ncbi.nlm.nih.gov/pubmed/32086950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.16373
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak